Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Prospective Study Comparing Three Regimens of Oxaliplatin Plus Fluoropyrimidine and Avastin for Evaluation of Safety and Tolerability in First-line Treatment of Patients With Advanced Colorectal Cancer.

NCT00399750 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00399750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00399750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Prospective Study Comparing Three Regimens of Oxaliplatin Plus Fluoropyrimidine and Avastin for Evaluation of Safety and Tolerability in First-line Treatment of Patients With Advanced Colorectal Cancer.
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
June 30, 2005
Enrollment
373
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer